Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Laguna M, Albers P, Algaba F, et al. (2020) EAU guidelines on testicular cancer. EAU Guidelines
2. Huddart RA, Reid AH, Mayer E, Sohaib SA, Nicol D (2019) Clinical outcomes of minimally invasive retroperitoneal lymph node dissection and single dose carboplatin for clinical stage IIa seminoma: American society of. Clin Oncol 37:530–530
3. Albers P, Hiester A, Grosse Siemer R, Lusch A (2019) The PRIMETEST trial: Interim analysis of a phase II trial for primary retroperitoneal lymph node dissection (RPLND) in stage II A/B seminoma patients without adjuvant treatment. Ame Soc Clin Oncol 37:507–507
4. Stephenson AJ, Bosl GJ, Motzer RJ, Bajorin DF, Stasi JP, Sheinfeld J (2007) Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. J Clin Oncol 25(35):5597–5602
5. Hamilton RJ, Nayan M, Anson-Cartwright L et al (2019) Treatment of relapse of clinical stage I nonseminomatous germ cell tumors on surveillance. J Clin Oncol. https://doi.org/10.1200/jco.18.01250 (published Online First: Epub Date)
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献